600993.SS · 马应龙
China A-shares · RS rating 80 · As of 2026-10-14
| Price | 24.56 CNY |
|---|---|
| 1-day change | +3.5% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 92 / 58 / 58 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 44 / 22 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -1.6% |
| Distance from 52-week high | +18.5% |
| Market cap (USD) | $1.5B |